Related Experiment Videos
Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial
Guido Grassi1, Fosca Quarti-Trevano, Raffaella Dell'oro
1Clinica Medica, Ospedale San Gerardo, Via Pergolesi 33, 20052 Monza (Milan), Italy. guido.grassi@unimib.it
Insights
Effective blood pressure control is crucial for stroke prevention. Drugs targeting the renin-angiotensin system may offer additional cerebrovascular protection beyond lowering blood pressure.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Blood pressure control is essential for preventing initial and recurrent strokes.
- Various antihypertensive drug classes can help prevent cerebrovascular events.
- Emerging evidence suggests specific benefits from renin-angiotensin system inhibitors.
Purpose of the Study:
- To review the cerebrovascular protection offered by antihypertensive treatments.
- To analyze findings from recent meta-analyses and the PRoFESS trial.
Main Methods:
- Review of recent meta-analyses on antihypertensive drug efficacy for stroke prevention.
- Analysis of data from the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial.
Main Results:
- All antihypertensive drug classes contribute to stroke prevention through blood pressure reduction.
- Drugs targeting the renin-angiotensin system (ACE inhibitors, ARBs) may provide additional cerebrovascular benefits.
- The PRoFESS trial and meta-analyses support the role of antihypertensives in cerebrovascular protection.
Conclusions:
- Optimizing blood pressure control is paramount for stroke prevention.
- Renin-angiotensin system inhibitors show promise for enhanced cerebrovascular protection.
- Antihypertensive therapy remains a cornerstone in managing cerebrovascular risk.
Abstract:
Blood pressure control is the cornerstone of therapeutic interventions aimed at preventing first strokes and recurrent strokes. All antihypertensive drug classes may be useful in preventing cerebrovascular events, depending on their efficacy in lowering elevated blood pressure values and achieving blood pressure control. However, recent findings indicate that drugs acting on the renin-angiotensin system (-angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers) may exert cerebrovascular protective effects in addition to blood pressure reduction. This article examines the cerebrovascular protection provided by antihypertensive drug treatment in the light of the results of recent meta-analyses and of the findings of the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Antihypertensive Drugs: Direct Renin Inhibitors
Venous Thrombosis III: Interprofessional Care